- 期刊
- OpenAccess
Plasma Growth Arrest‑Specific Protein 6 Expression in Uremic Patients with Type 2 Diabetes
摘要
Background: Diabetic kidney disease is a major cause of uremia worldwide; recently, controversial roles for growth arrest-specific protein 6 (GAS 6) have been revealed in the pathogenesis of diabetic nephropathy. A better understanding of the association between GAS6 and diabetic nephropathy may lead to the development of novel therapeutic approaches for the prevention and treatment of diabetic uremia. Objectives: The aim of this study was to investigate the levels of GAS6 and its role in uremic patients with Type 2 diabetes. Materials and Methods: A total of 109 adults were recruited, of whom 23 had Type 2 diabetes and uremia and 56 had newly diagnosed Type 2 diabetes without remarkable nephropathy; thirty individuals with normal glucose tolerance without significant clinical comorbidities served as controls. Plasma GAS6 concentration and common anthropometric and biochemical variables were analyzed. Results: Plasma GAS6 levels were significantly lower in patients with Type 2 diabetes than in controls regardless of nephropathy (P ＜ 0.001). A trend in declined level of GAS6 among the three groups was also observed. In addition, GAS6 levels were significantly inversely correlated with plasma creatinine, blood urea nitrogen, and uric acid levels in all patients (P ＜ 0.01 for all comparisons). In multivariate logistic regression analysis, higher plasma GAS6 concentration was significantly associated with decreased risk of diabetic uremia, even after adjusting for age, sex, and fasting glucose (C-statistic, 0.72; 95% confidence interval 0.57-0.92; P ＜ 0.01). Conclusions: Our results suggest that plasma GAS6 levels are associated with Type 2 diabetes and may play a role in development of diabetic uremia.
延伸閱讀
- Qu, H., Deng, H., & Hu, Z. (2013). Plasma Progranulin Concentrations Are Increased in Patients with Type 2 Diabetes and Obesity and Correlated with Insulin Resistance. Mediators of Inflammation, 2013(), 54-59-105. https://doi.org/10.1155/2013/360190
- Klupa, T., Klupa, T. B., Matejko, B., Mrozinska, S., & Malecki, M. T. (2015). The Impact of a Pure Protein Load on the Glucose Levels in Type 1 Diabetes Patients Treated with Insulin Pumps. International Journal of Endocrinology, 2015(), 326-329-036. https://doi.org/10.1155/2015/216918
- Stanislawowska, M. R., Skrzypkowska, M., Mysliwska, J., & Mysliwiec, M. (2013). The Serum IL-6 Profile and Treg/Th17 Peripheral Cell Populations in Patients with Type 1 Diabetes. Mediators of Inflammation, 2013(), 533-539-049. https://doi.org/10.1155/2013/205284
- Cheng, C. C. (2014). Glucose Regulated Protein 78 (GRP78): A Role on Targeted Drug Delivery for Gastric Cancer [doctoral dissertation, Taipei Medical University]. Airiti Library. https://doi.org/10.6831/TMU.2014.00004
- Ma, S. G., Jin, Y., Hu, W., Bai, F., Xu, W., & Yu, W. N. (2012). Evaluation of Ischemia-Modified Albumin and C-Reactive Protein in Type 2 Diabetics With and Without Ketosis. Biomarker Insights, 2012(), 19-26. https://doi.org/10.4137/BMI.S9060